CRA was engaged by a financial services company in a Lanham Act litigation matter. CRA’s client was accused of infringing the trademark of a customer and competitor in the field of payment systems. CRA provided rebuttal analyses and trial testimony regarding the plaintiff’s diminution of value, corrective advertising, and unjust enrichment damages claims of approximately $13 million. In addition, CRA was instrumental in assisting trial counsel with cross-examination preparation for key plaintiff expert and fact witnesses.
Life Sciences Litigation Insights: April 2022
CRA’s Life Sciences Litigation team provides periodic summaries of notable developments in litigation. In this issue, we share notable cases from 2021 and...